What is Heal?
Heal operates a comprehensive health technology platform that integrates web and mobile applications to provide telehealth and house call services. Founded in 2014 and headquartered in Pacific Palisades, California, the company specializes in offering modern doctor house calls, one-touch telemedicine, and remote monitoring solutions, with a particular focus on serving seniors. Heal's model aims to bring convenient and accessible healthcare directly to patients, bridging the gap between traditional in-person visits and remote medical consultations.
How much funding has Heal raised?
Heal has raised a total of $177.7M across 5 funding rounds:
Angel/Seed
$5M
Series A
$38M
Series B
$14.6M
Unspecified
$20M
Corporate Investment
$100M
Angel/Seed (2015): $5M with participation from March Capital Partners, Slow Ventures, and Pritzker Group Venture Capital
Series A (2016): $38M led by HashtagOne, Breyer Capital, and Slow Ventures
Series B (2016): $14.6M, investors not publicly disclosed
Unspecified (2018): $20M featuring RLJ Equity Partners, Trans-Pacific Technology Fund, IRA Capital, Bascom Ventures, and Inflection Capital
Corporate Investment (2020): $100M backed by Humana
Key Investors in Heal
Humana
Humana is a health insurance company committed to helping people live healthy and happy lives by offering personalized care and solutions. They focus on listening to members and creating tailored approaches to health and well-being, while also investing in and improving local communities.
March Capital Partners
March Capital is a growth-stage venture firm that specializes in investing in enterprise technology companies with established product-market fit, aiming to scale them into mission-critical global platforms.
IRA Capital
IRA Capital is a prominent private equity firm specializing in alternative investments, particularly in U.S. commercial real estate, collaborating with institutional investors to deploy capital across various property sectors.
What's next for Heal?
The recent major strategic investment signals a pivotal phase for Heal, likely indicating a move towards scaling operations, expanding service offerings, or further developing its technological infrastructure. Given the enterprise-level funding context, Heal is positioned to enhance its market penetration and potentially explore new healthcare verticals or geographic regions. This strategic financing will be crucial for solidifying its competitive advantage in the rapidly evolving telehealth and home healthcare market, enabling further innovation in patient care delivery and remote health management.
See full Heal company page
